China Medical System Holdings Limited
China Medical System Holdings Limited (CHSYF) Revenue
Annual & quarterly revenue history · segment & region breakdown
CHSYF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsChina Medical System Holdings Limited trailing twelve-month (TTM) revenue is $15.61B, an increase of 7.11% year-over-year from $8.00B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $8.00B | +$0.53B | +7.11% |
| 2024-12-31 | $7.47B | -$0.54B | -6.79% |
| 2023-12-31 | $8.01B | -$1.14B | -12.43% |
| 2022-12-31 | $9.15B | +$0.81B | +9.75% |
| 2021-12-31 | $8.34B | +$1.39B | +20.03% |
| 2020-12-31 | $6.95B | +$0.87B | +14.36% |
| 2019-12-31 | $6.07B | +$0.64B | +11.78% |
| 2018-12-31 | $5.43B | +$0.08B | +1.58% |
| 2017-12-31 | $5.35B | +$0.45B | +9.14% |
| 2016-12-31 | $4.90B | +$1.35B | +37.92% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare CHSYF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income China Medical System Holdings Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
China Medical System Holdings Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CNY.
Data sourced from China Medical System Holdings Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CHSYF revenue · 4 questionsCHSYF's trailing twelve-month (TTM) revenue is $15.61B. That is an increase of 7.11% year-over-year from $8.00B in FY2025.
▸ Source: FMP · China Medical System Holdings Limited SEC filings · GAAP · China Medical System Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026